Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?

Area of Science:

• Oncology
• Gene Therapy
• Virology

Background:

• Gene therapy for cancer is promising but limited by inefficient in vivo delivery to tumor sites.
• Lentiviral vectors (LVs) offer efficient gene delivery to both dividing and non-dividing cells.
• Pseudotyping LVs with viral glycoproteins alters tropism for cell-type specificity.

Purpose of the Study:

• To review pseudotyped lentiviral vectors (LVs) for cancer gene therapy.
• To summarize current applications of pseudotyped LVs in anti-cancer studies.
• To discuss the clinical translation potential of pseudotyped LVs.

Main Methods:

• Review of studies on lentiviral vector pseudotyping.
• Analysis of LV tropism modification and cell-type specificity.
• Evaluation of pseudotyped LVs in various cancer models.

Main Results:

• Pseudotyped LVs demonstrate altered tropism and tumor-specific transduction.
• Selective killing of tumor cells has been achieved using pseudotyped LVs.
• High gene delivery efficiency in mammalian cells in vivo is a key feature.

Conclusions:

• Pseudotyped LVs are promising tools for cancer gene therapy due to targeted delivery.
• Further research into pseudotyped LVs can advance their clinical application in oncology.
• Targeted gene delivery via pseudotyped LVs holds potential for effective cancer treatment.